Categorie
Furadantin Retard
Les marques,
Furadantin Retard
Analogs
Furadantin Retard
Les marques melange
No information avaliable
Furadantin Retard
Formule chimique
C8H6N4O5
Furadantin Retard
RX lien
http://www.rxlist.com/cgi/generic/nitro25m.htm
Furadantin Retard
FDA fiche
Furadantin Retard
msds (fiche de securite des materiaux)
Furadantin Retard
Synthese de reference
Aucune information disponible
Furadantin Retard
Poids moleculaire
238.157 g/mol
Furadantin Retard
Point de fusion
263 oC
Furadantin Retard
H2O Solubilite
79,5 mg / L
Furadantin Retard
Etat
Solid
Furadantin Retard
LogP
-0.04
Furadantin Retard
Formes pharmaceutiques
Tablet
Furadantin Retard
Indication
Pour le traitement de l'infection des voies urinaires
Furadantin Retard
Pharmacologie
Nitrofurantoin, un nitrofurane agent antibactérien, est disponible sous forme microcristalline et macrocristallin pour traiter les infections des voies urinaires causées par de nombreuses bactéries gram-négatives et certaines bactéries Gram-positives.
Furadantin Retard
Absorption
Aucune information disponible
Furadantin Retard
Toxicite
Aucune information disponible
Furadantin Retard
Information pour les patients
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
Furadantin Retard
Organismes affectes
Gram négatif et certaines bactéries Gram positives